Moderna Inc. Stock Slides 5.0%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slipped 5.0% to $213.74 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the NASDAQ Composite Index falling 0.4% to 27,245.90.

The stock's fall snapped a three-day winning streak.

Moderna Inc. closed 5.0% below its 52-week high of $225.00, which the company reached on October 9th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $263.73, Pfizer Inc. rose 0.4% to $28.40, and Gilead Sciences Inc. fell 0.49% to $150.43.

Trading volume totaled 12.8 million, compared to the 50-day average of 22.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 12, 2026 16:33 ET (20:33 GMT)